Literature DB >> 26154889

Early stage radiation-induced lung injury detected using hyperpolarized (129) Xe Morphometry: Proof-of-concept demonstration in a rat model.

Alexei Ouriadov1, Matthew Fox1,2, Elaine Hegarty1, Grace Parraga1,2, Eugene Wong2,3, Giles E Santyr1,2,4.   

Abstract

PURPOSE: Radiation-induced lung injury (RILI) is still the major dose-limiting toxicity related to lung cancer radiation therapy, and it is difficult to predict and detect patients who are at early risk of severe pneumonitis and fibrosis. The goal of this proof-of-concept preclinical demonstration was to investigate the potential of hyperpolarized (129) Xe diffusion-weighted MRI to detect the lung morphological changes associated with early stage RILI.
METHODS: Hyperpolarized (129) Xe MRI was performed using eight different diffusion sensitizations (0.0-115 s/cm(2) ) in a small group of control rats (n = 4) and rats 2 wk after radiation exposure (n = 5). The diffusion-weighted images were used to obtain morphological estimates of the pulmonary parenchyma including external radius (R), internal radius (r), alveolar sleeve depth (h), and mean airspace chord length (Lm ). The histological mean linear intercept (MLI) were obtained for five control and five irradiated animals.
RESULTS: Mean R, r, and Lm were both significantly different (P < 0.02) in the irradiated rats (74 ± 17 µm, 43 ± 12 µm, and 54 ± 17 µm, respectively) compared with the control rats (100 ± 12 µm, 67 ± 10 µm, and 79 ± 12 µm, respectively). Changes in measured Lm values were consistent with changes in MLI values observed by histology.
CONCLUSIONS: Hyperpolarized (129) Xe MRI provides a way to detect and measure regional microanatomical changes in lung parenchyma in a preclinical model of RILI. Magn Reson Med 75:2421-2431, 2016.
© 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ADC; RILI; anisotropy; hyperpolarized; lung; morphometry; xenon-129

Mesh:

Substances:

Year:  2015        PMID: 26154889     DOI: 10.1002/mrm.25825

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  7 in total

1.  In vivo imaging of the progression of acute lung injury using hyperpolarized [1-13 C] pyruvate.

Authors:  Mehrdad Pourfathi; Yi Xin; Stephen J Kadlecek; Maurizio F Cereda; Harrilla Profka; Hooman Hamedani; Sarmad M Siddiqui; Kai Ruppert; Nicholas A Drachman; Jennia N Rajaei; Rahim R Rizi
Journal:  Magn Reson Med       Date:  2017-01-11       Impact factor: 4.668

2.  Application of a stretched-exponential model for morphometric analysis of accelerated diffusion-weighted 129Xe MRI of the rat lung.

Authors:  Alexei V Ouriadov; Matthew S Fox; Andras A Lindenmaier; Elaine Stirrat; Hacene Serrai; Giles Santyr
Journal:  MAGMA       Date:  2020-07-06       Impact factor: 2.310

Review 3.  Magnetic resonance imaging with hyperpolarized agents: methods and applications.

Authors:  Erin B Adamson; Kai D Ludwig; David G Mummy; Sean B Fain
Journal:  Phys Med Biol       Date:  2017-04-06       Impact factor: 3.609

Review 4.  Diffusion lung imaging with hyperpolarized gas MRI.

Authors:  Dmitriy A Yablonskiy; Alexander L Sukstanskii; James D Quirk
Journal:  NMR Biomed       Date:  2015-12-16       Impact factor: 4.044

5.  Noninvasive quantification of alveolar morphometry in elderly never- and ex-smokers.

Authors:  Gregory A Paulin; Alexei Ouriadov; Eric Lessard; Khadija Sheikh; David G McCormack; Grace Parraga
Journal:  Physiol Rep       Date:  2015-10

Review 6.  In vivo methods and applications of xenon-129 magnetic resonance.

Authors:  Helen Marshall; Neil J Stewart; Ho-Fung Chan; Madhwesha Rao; Graham Norquay; Jim M Wild
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2020-12-09       Impact factor: 9.795

7.  Detection of regional radiation-induced lung injury using hyperpolarized 129Xe chemical shift imaging in a rat model involving partial lung irradiation: Proof-of-concept demonstration.

Authors:  Brandon Zanette; Elaine Stirrat; Salomeh Jelveh; Andrew Hope; Giles Santyr
Journal:  Adv Radiat Oncol       Date:  2017-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.